INSIGHTS ON DRUG DEVELOPMENT
-
Enabling Quality By Design
Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.
-
T3P – A Green Solution For Peptide Coupling, Water Removal Reactions
The session focuses on the use of T3P (propanephosphonic acid anhydride) in amidation and peptide coupling reactions, including both liquid-phase and solid-phase peptide synthesis.
-
Method Development For Forced Degradation Of GLP-1 Agonist
Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
-
How The Accelerator™ Drug Development Model Enhances eNPV
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.
-
Predicting Food Effects In Oral Drug Delivery Using PBPK Modeling7/15/2026
Learn how integrated PBPK and molecular dynamics modeling predicted an ~11% fed-state Cmax increase for fenofibrate, giving formulation teams earlier, mechanistic insight into food-dependent absorption.
-
Assessing Particle Generation In A Single-Use Mixing System11/13/2025
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
White Paper: Spray Drying Biologics: An Alternative To Freeze Drying10/16/2024
Explore how innovative drying technologies can enhance the stability and efficacy of biologics, ensuring successful outcomes in this rapidly growing sector of the pharmaceutical industry.
-
Polymorphism 101: What Early-Stage Drug Developers Need To Know To Reduce Risk5/18/2026
Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.
-
Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection8/27/2025
The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.
DRUG DEVELOPMENT SOLUTIONS
-
Our highly skilled team of chemists and process engineers, combined with a science-driven project management approach, ensures seamless execution at every stage.
-
The Percepta Platform is a portfolio of software applications and a technology ecosystem for predicting and managing physicochemical, ADME/Tox, and other molecular property data.
With Percepta applications you can predict molecular properties from structure, and train models with experimental data. You can even include custom models created in-house to centrally manage in silico calculations and training sets for distribution so that everyone calculating property data is using up-to-date information.
-
Microscope Camera K3C
For Life Science and Industry Imaging Applications and Analysis
The K3C color and K3M monochrome cameras are your solutions for fast and reliable analytical tasks typically done for life science, industrial, and clinical applications. These cameras empower you to image a vast range of challenging samples with color-brightfield and fluorescence microscopy. Examples include fluorescently labeled and stained tissues and cells, particles for cleanliness analysis, steel, and forensic evidence.
-
Understand and predict human response earlier in the drug development process, and harness the advantages of Organ-on-a-Chip technology without needing to invest in capital equipment or train personnel.
-
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.